Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
ABX 51.91 −0.6% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.75 +9.4% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2% ABX 51.91 −0.6% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.75 +9.4% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2%

Healthcare

Page 4
  1. Jun 24, 2026 · 20:46 · ZYUS · Routine +

    Clinical-stage biotech secures incremental insider debt to fund working capital amid Phase 2a trial completion and filing delays.

    ZYUS Life Sciences Corporation Announces Closing of Fourth Tranche of Secured Loan Financing

    01
  2. Jun 24, 2026 · 17:01 · NRX · Routine +

    Early-stage exosome developer secures Mexican distribution MOU while navigating a tight cash runway and going concern warning.

    Exo-Top, NurExone's wholly owned U.S. Subsidiary, Enters Into Binding MOU For Naive Exosome Distribution in Mexico

    02
  3. Jun 24, 2026 · 08:30 · QNTM · Neutral

    A pre-revenue biotech touting an MS drug's potential while its lead IND sits on clinical hold and the company stays silent on the setback in its latest marketing push.

    The Quest to Repair What Multiple Sclerosis Takes Away

    03
  4. Jun 24, 2026 · 08:00 · ZCT · Neutral

    Zero Candida announced officially been granted Patent No. 12654025B2 -- a meaningful milestone that reflects our commitment to innovation, technology, and long-term impact

    Zero Candida announced officially been granted Patent No. 12654025B2 -- a meaningful milestone that reflects our commitment to innovation, technology, and long-term impact

    04
  5. Jun 24, 2026 · 06:01 · HELP · Routine +

    Helus Pharma(TM) Announces US$50 Million Underwritten Offering

    Helus Pharma(TM) Announces US$50 Million Underwritten Offering

    05
  6. Jun 24, 2026 · 06:00 · HELP · Routine −

    Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress

    Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress

    06
  7. Jun 24, 2026 · 00:16 · EYE · Routine +

    Pre-revenue nano-optics startup scales US distribution via asset-light lab partnerships while navigating a steep cash burn and going-concern reality.

    Rise Nano Optics Announces Strategic Partnership with SportifEye Optics to Produce and Commercialize SpectraGuard(TM) Lenses in the United States

    07
  8. Jun 23, 2026 · 21:30 · PHA · Game Changer

    CCAA Filing Caps Distressed Decline; Equity Likely Wiped Out in Going-Concern Sale

    Premier Health obtains creditor protection under CCAA

    08
  9. Jun 23, 2026 · 18:00 · ONCO · Routine +

    Preclinical Oncology Developer Secures Polymer Partner to De-Risk ONC010 Manufacturing Ahead of IND Filing

    Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010

    09
  10. Jun 23, 2026 · 17:20 · BNXT · Routine −

    Cash-burning sublingual drug delivery platform secures survival capital amid preclinical milestones.

    BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption

    10
  11. Jun 23, 2026 · 08:31 · BUX · Routine +

    BioMark Diagnostics Secures Global IP for Metabolomics Lung Cancer Test, Eyes 2026 Commercial Launch Amid Tight Cash Position

    BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test

    11
  12. Jun 23, 2026 · 08:30 · 4151 · Routine +

    Rare disease and oncology portfolio advancing with regulatory wins, expanded access, and strategic pipeline consolidation.

    The XLH Network and Kyowa Kirin Launch the XLH Community Guidebook to Help People Navigate Lifelong Journey with XLH

    12
  13. Jun 23, 2026 · 08:19 · PHA · Material −

    Premier Health of America Announces CCAA Proceedings

    Premier Health of America Announces CCAA Proceedings

    13
  14. Jun 23, 2026 · 08:00 · AIDR · Routine +

    AI-driven telemedicine platform expanding U.S. payer network, but burning cash with a going concern warning.

    Rocket Doctor Partners with Mindstride to Expand Access to After-Hours Healthcare Across Ontario, Alberta and British Columbia

    14
← Newer Older →